Literature DB >> 27822666

The Top 5 Neurotransmitters from a Clinical Neurologist's Perspective.

Daniel Kondziella1.   

Abstract

Neurologists are proficient in neuroanatomy and -physiology but their understanding of neurochemistry tends to be mediocre. As a rule, we do not think in biochemical pathways and complex metabolic interactions but rather associate a few neurotransmitters with well-known brain diseases or drugs that we routinely prescribe. Most of us can hardly come up with more than a handful of relevant neurochemicals. From our point of view the most important neurotransmitters are, in alphabetical order, acetylcholine (associated with Alzheimer's disease and myasthenia gravis), dopamine (Parkinson's disease), glutamate and GABA (epilepsy and seizures), and serotonin (major depression; although this is arguably the domain of psychiatrists). In this commentary, the author presents the knowledge derived from neurochemistry research that has proven useful for clinical neurological practice. In addition, he explains what biochemists, basic neuroscientists and other non-neurologists need to consider in the encounter with a clinical neurologist.

Entities:  

Keywords:  Acetylcholine; Alzheimer’s disease; Dopamine; GABA; Glutamate; Neurology; Parkinson’s disease; Serotonin

Mesh:

Substances:

Year:  2016        PMID: 27822666     DOI: 10.1007/s11064-016-2101-z

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  7 in total

1.  3,4-Dihydroxyphenylalanine and 5-hydroxytryptophan as reserpine antagonists.

Authors:  A CARLSSON; M LINDQVIST; T MAGNUSSON
Journal:  Nature       Date:  1957-11-30       Impact factor: 49.962

2.  Anti-N-methyl-D-aspartate receptor encephalitis is an important differential diagnosis in acute psychiatric disease.

Authors:  A Jørgensen; B S Hansen; S Stanislaus; S Düring; M B Jørgensen; L H Pinborg; D Kondziella
Journal:  Acta Psychiatr Scand       Date:  2014-10-23       Impact factor: 6.392

Review 3.  Rivastigmine for Alzheimer's disease.

Authors:  Jacqueline S Birks; John Grimley Evans
Journal:  Cochrane Database Syst Rev       Date:  2015-04-10

4.  Cost of disorders of the brain in Europe 2010.

Authors:  Anders Gustavsson; Mikael Svensson; Frank Jacobi; Christer Allgulander; Jordi Alonso; Ettore Beghi; Richard Dodel; Mattias Ekman; Carlo Faravelli; Laura Fratiglioni; Brenda Gannon; David Hilton Jones; Poul Jennum; Albena Jordanova; Linus Jönsson; Korinna Karampampa; Martin Knapp; Gisela Kobelt; Tobias Kurth; Roselind Lieb; Mattias Linde; Christina Ljungcrantz; Andreas Maercker; Beatrice Melin; Massimo Moscarelli; Amir Musayev; Fiona Norwood; Martin Preisig; Maura Pugliatti; Juergen Rehm; Luis Salvador-Carulla; Brigitte Schlehofer; Roland Simon; Hans-Christoph Steinhausen; Lars Jacob Stovner; Jean-Michel Vallat; Peter Van den Bergh; Peter Van den Bergh; Jim van Os; Pieter Vos; Weili Xu; Hans-Ulrich Wittchen; Bengt Jönsson; Jes Olesen
Journal:  Eur Neuropsychopharmacol       Date:  2011-09-15       Impact factor: 4.600

Review 5.  Management of Serotonin Syndrome and Neuroleptic Malignant Syndrome.

Authors:  Linn E Katus; Steven J Frucht
Journal:  Curr Treat Options Neurol       Date:  2016-09       Impact factor: 3.598

Review 6.  Management of Narcolepsy.

Authors:  Lucie Barateau; Régis Lopez; Yves Dauvilliers
Journal:  Curr Treat Options Neurol       Date:  2016-10       Impact factor: 3.598

7.  Impulse Control Disorders in Parkinson's Disease are Associated with Alterations in Reward-Related Cortical Oscillations.

Authors:  Nicolas Carriere; Jean-Louis Bourriez; Arnaud Delval; Philippe Derambure; Luc Defebvre; Kathy Dujardin
Journal:  J Parkinsons Dis       Date:  2016-06-28       Impact factor: 5.568

  7 in total
  3 in total

Review 1.  GABAA receptors: structure, function, pharmacology, and related disorders.

Authors:  Amr Ghit; Dina Assal; Ahmed S Al-Shami; Diaa Eldin E Hussein
Journal:  J Genet Eng Biotechnol       Date:  2021-08-21

Review 2.  Therapeutic Anti-Depressant Potential of Microbial GABA Produced by Lactobacillus rhamnosus Strains for GABAergic Signaling Restoration and Inhibition of Addiction-Induced HPA Axis Hyperactivity.

Authors:  Fernanda-Marie Tette; Samuel K Kwofie; Michael D Wilson
Journal:  Curr Issues Mol Biol       Date:  2022-03-22       Impact factor: 2.976

3.  Ionotropic Receptors as a Driving Force behind Human Synapse Establishment.

Authors:  Lucas Henriques Viscardi; Danilo Oliveira Imparato; Maria Cátira Bortolini; Rodrigo Juliani Siqueira Dalmolin
Journal:  Mol Biol Evol       Date:  2021-03-09       Impact factor: 16.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.